Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

362 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.

Snyder BR, Chiu AM, Prockop DJ, Chan AW.

PLoS One. 2010 Feb 22;5(2):e9347. doi: 10.1371/journal.pone.0009347.

0

0

0

PUBMED

Frontal behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness."

Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Wang C, Stout JC, Ross CA, Aylward E, Carlozzi NE, Queller S; Predict-HD Investigators of the Huntington Study Group..

J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207. doi: 10.1176/appi.neuropsych.22.2.196.

0

0

0

PUBMED

Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease.

Pandey M, Mohanakumar KP, Usha R.

J Bioenerg Biomembr. 2010 Jun;42(3):217-26. doi: 10.1007/s10863-010-9288-5. Review.

0

0

0

PUBMED

Late-onset Huntington disease with intermediate CAG repeats: true or false?

Groen JL, de Bie RM, Foncke EM, Roos RA, Leenders KL, Tijssen MA.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):228-30. doi: 10.1136/jnnp.2008.170902.

0

0

0

PUBMED

Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.

Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ.

AJNR Am J Neuroradiol. 2010 Jun;31(6):1036-41. doi: 10.3174/ajnr.A2018.

0

0

0

PUBMED

Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease.

Perry GM, Tallaksen-Greene S, Kumar A, Heng MY, Kneynsberg A, van Groen T, Detloff PJ, Albin RL, Lesort M.

Hum Mol Genet. 2010 Sep 1;19(17):3354-71. doi: 10.1093/hmg/ddq247.

0

0

0

PUBMED

Sydenham chorea and Hashimoto thyroiditis: an unusual association.

Yildiz OK, Gokcay A, Gokcay F, Karasoy H.

J Child Neurol. 2010 Jun;25(6):757-8. doi: 10.1177/0883073809343721.

0

0

0

PUBMED

Neuroinflammation in Huntington's disease.

Möller T.

J Neural Transm (Vienna). 2010 Aug;117(8):1001-8. doi: 10.1007/s00702-010-0430-7. Review.

0

0

0

PUBMED

Huntington's disease.

Roze E, Bonnet C, Betuing S, Caboche J.

Adv Exp Med Biol. 2010;685:45-63. Review.

0

0

0

PUBMED

Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.

Bech S, Petersen T, Nørremølle A, Gjedde A, Ehlers L, Eiberg H, Hjermind LE, Hasholt L, Lundorf E, Nielsen JE.

Parkinsonism Relat Disord. 2010 Jan;16(1):12-5. doi: 10.1016/j.parkreldis.2009.06.006.

0

0

0

PUBMED

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.

Lundin A, Dietrichs E, Haghighi S, Göller ML, Heiberg A, Loutfi G, Widner H, Wiktorin K, Wiklund L, Svenningsson A, Sonesson C, Waters N, Waters S, Tedroff J.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):260-4. doi: 10.1097/WNF.0b013e3181ebb285.

0

0

0

PUBMED

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J.

Mov Disord. 2010 Jul 15;25(9):1163-9. doi: 10.1002/mds.22953.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy